Peapod Lane Capital LLC
Position in MGX — Metagenomi Therapeutics, Inc.
CIK 2050979
Bedford Hills, NY
Position in MGX
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$692,459
-$113,738 QoQ
Shares Held
516,761
+3.8% QoQ
Ownership
1.37%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 80%
Shared 0%
None 20%
Common Shares in MGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Peapod Lane Capital LLC holds $11,855,295 across 12 Biotechnology names. MGX ranks #9 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | FDMT |
4D Molecular Therapeutics, Inc.
|
241,480 | $2,248,178 | |
| 2 | PLRX |
Pliant Therapeutics, Inc.
|
1,288,578 | $1,623,608 | |
| 3 | AVIR |
Atea Pharmaceuticals, Inc.
|
272,820 | $1,467,771 | |
| 4 | NKTX |
Nkarta, Inc.
|
676,212 | $1,426,807 | |
| 5 | KZR |
Kezar Life Sciences, Inc.
|
126,692 | $940,054 | |
| 6 | ZNTL |
Zentalis Pharmaceuticals, Inc.
|
366,868 | $858,471 | |
| 7 | CLYM |
Climb Bio, Inc.
|
108,878 | $745,814 | |
| 8 | SEER |
Seer, Inc.
|
438,581 | $736,816 |
All Filings in MGX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $692,459 | 516,761 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $806,197 | 497,653 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $1,217,741 | 513,815 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $752,001 | 508,109 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $479,341 | 352,457 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $1,267,878 | 351,213 | Shares | Sole | 2025-01-29 | |
| No filing history on record for this holder in this stock. | ||||||